Bio-Rad Laboratories, Inc.

BIO·NYSE·Healthcare
Compare
379.99+5.08 (+1.35%)today
At close: Nov 4, 4:02 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close374.91
Open380.05
Day range371.85382.00
52-week range236.73396.23
Off day high−0.53%
Off 52-week high−4.10%
Volume281.80K
Avg. volume (3M)249.34K
Market cap10.16B
EPS (TTM)7.89
Forward P/E38.99
P/E ratio (TTM)48.16
Dividend yield—
Beta (5Y)1.06
Shares outstanding21.68M
Short interest6.91% of float
Earnings dateNov 4, 2026
Analyst target335.00
Profit margin8.59%

Against its peers

Compare in full ›
BIO BRKR 1302.HK NEOG LAB 49Z.F
Market cap 10.16B 9.72B 7.20B 2.72B 243.14M 154.56M
P/E (TTM) 48.2 — 163.5 — — —
Forward P/E 39.0 26.5 — 27.7 -61.6 —
Price/book 1.4 4.2 1.9 1.3 0.4 0.1
Dividend yield — 0.31% — — — —
1-year change +23.96% +62.27% −13.99% +108.36% −44.64% +7.89%
Today +1.35% +12.90% −1.51% +2.98% +0.85% +3.30%

The closest companies by business and industry (Medical Devices). Prices may be delayed up to 15 min.

Latest news

All BIO news ›
Stock Titan··3 outletsPositive

Precision BioSciences to Report Third Quarter 2026 Financial Results on November 3, 2026

JELD-WEN Announces Commencement of Exchange Offer and Consent Solicitation for Outstanding 4.875% Senior Notes due 2027 Linde Reports Third-Quarter 2026 Results TAL Education Group Announces Unaudited Financial Results for the Second…

More from 2 other outlets
TradingView·Negative

C-RAD's Interim Report Q3’26

”A challenging quarter, but a stronger C-RAD portfolio” The third quarter was challenging for us, with order intake and revenue both lower than the corresponding quarter last year. Order intake was MSEK 76 (106) and net revenue was MSEK 85…

From the 4Search news index, newest first.

In the news

21mentions in 30 days
4with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 21 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance